Predicting Mortality in Patients with Cirrhosis of Liver with Application of Neural Network Technology
Overview
Affiliations
Background: Prediction of mortality from cirrhosis is important in planning optimal timing of liver transplantation and other interventions. We evaluated the role of the Artificial Neural Network (ANN), which uses non-linear statistics for pattern recognition in predicting one-year liver disease-related mortality using information available during initial clinical evaluation.
Methods: The ANN was constructed using software with data from a training set (n = 46) selected at random from a cohort of adult cirrhotics (n = 92). After training, validation was performed in the remaining patients (n = 46) whose outcome in terms of one-year mortality was unknown to the network. The performance of ANN was compared to those of a logistic regression model (LRM) and Child-Pugh's score (CPS). Death (related to cirrhosis/its complications) within one year of inclusion was the outcome variable. The ANN was also tested in an external validation sample (EVS, n = 62) from another hospital.
Results: Patients in the EVS were younger (mean age, 41 vs 45 years), infrequently of alcoholic etiology (5% vs 49%), had less severe disease (mean CPS 6.6 vs 10.8), and had lower one-year mortality (13 vs 46%). In the internal validation sample, ANN's accuracy was 91%, sensitivity 90% and specificity 92% in prediction of one-year mortality; area under the receiver-operating characteristic (ROC) curve was 0.94. The performance of the LRM (accuracy 74%) and the CPS (accuracy 55%) was significantly worse than ANN (P < 0.05, McNemar's test). Despite differences in the characteristics of the two groups, the ANN performed fairly well in the EVS (accuracy of 90%, area under curve 0.85).
Conclusions: ANN can accurately predict one-year mortality in cirrhosis and is superior to CPS and LRM.
The Role of Machine Learning Models in Predicting Cirrhosis Mortality: A Systematic Review.
Mohamud K, Elzubair Eltahir S, Ahmed Alhardalo H, Albashir H, Ali Mohamed Zain N, Abdelrahman Ibrahim M Cureus. 2025; 17(1):e78155.
PMID: 40026938 PMC: 11867977. DOI: 10.7759/cureus.78155.
Al Alawi A, Al Kaabi H, Al Falahi Z, Al-Naamani Z, Al Busafi S Oman Med J. 2024; 39(3):e632.
PMID: 39497942 PMC: 11532584. DOI: 10.5001/omj.2024.79.
Artificial intelligence-based evaluation of prognosis in cirrhosis.
Zhai Y, Hai D, Zeng L, Lin C, Tan X, Mo Z J Transl Med. 2024; 22(1):933.
PMID: 39402630 PMC: 11475999. DOI: 10.1186/s12967-024-05726-2.
Salkic N, Jovanovic P, Barisic Jaman M, Selimovic N, Pastrovic F, Grgurevic I Diagnostics (Basel). 2024; 14(10).
PMID: 38786278 PMC: 11119188. DOI: 10.3390/diagnostics14100981.
Chung Y, Jung J, Kim S Anesth Pain Med (Seoul). 2023; 18(1):21-28.
PMID: 36746898 PMC: 9902634. DOI: 10.17085/apm.22258.